Literature DB >> 26547220

IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response.

Mei Zeng1,2, Wantai Dang2, Baofeng Chen1, Yufeng Qing2, Wenguang Xie2, Mingcai Zhao2, Jingguo Zhou3.   

Abstract

Acute gouty arthritis (AGA) is an auto-inflammatory disease characterized by resolving spontaneously, which suggests that negative feedback loops control inflammatory and immunological responses to monosodium urate (MSU) crystals. By now, the molecular mechanism for spontaneous resolution of acute GA remains unclear; this study was undertaken to evaluate whether IL-37 is involved in spontaneous resolution of AGA. A total of 45 acute GA (AGA),29 non-acute GA (NAGA) male patients and 82 male health control (HC) were involved in this study, we measured IL-7 expression in the peripheral blood mononuclear cells (PBMCs), together with levels of IL-1β, IL-6, IL-10, TNF-α and TGF-β1 in the serum. Further, we either inhibited IL-37 expression in human PBMCs with siRNA or over-expressed the cytokine in human macrophages. Pro-inflammatory cytokine IL-1β, IL-6, and TNF-α expressions were significantly higher in the AGA group than in the NAGA or HC group (P < 0.05, respectively). However, anti-inflammatory IL-37, TGF-β1, and IL-10 were greater in the NAGA group than in the AGA and HC groups (P < 0.05, respectively). Expression of IL-37 in MSU crystal-treated macrophages inhibited the expression of pro-inflammatory cytokines, whereas the abundance of these cytokines increased with silencing of endogenous IL-37 in human blood cells. However, anti-inflammatory TGF-β1 and IL-10 expressions in these supernatants were unaffected by over-expression or knockdown of IL-37. Our study indicates that IL-37 is an important anti-inflammatory cytokine in AGA by suppressing the production of pro-inflammatory cytokines. Thus, IL-37 may provide a novel research target for the pathogenesis and therapy of GA.

Entities:  

Keywords:  Acute gouty arthritis; IL-37; MSU crystals; Spontaneous resolution

Mesh:

Substances:

Year:  2015        PMID: 26547220     DOI: 10.1007/s10067-015-3109-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

1.  Gout: new insights into an old disease.

Authors:  Fabio Martinon; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

2.  Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1.

Authors:  F S Di Giovine; S E Malawista; G Nuki; G W Duff
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

3.  Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase.

Authors:  Anna Scanu; Francesca Oliviero; Roberta Ramonda; Paola Frallonardo; Jean-Michel Dayer; Leonardo Punzi
Journal:  Ann Rheum Dis       Date:  2012-01-30       Impact factor: 19.103

4.  Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1.

Authors:  F Lioté; F Prudhommeaux; C Schiltz; R Champy; A Herbelin; E Ortiz-Bravo; T Bardin
Journal:  Arthritis Rheum       Date:  1996-07

Review 5.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

6.  Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation.

Authors:  Darshna R Yagnik; Betsy J Evans; Oliver Florey; Justin C Mason; R Clive Landis; Dorian O Haskard
Journal:  Arthritis Rheum       Date:  2004-07

7.  High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals.

Authors:  Anna Scanu; Francesca Oliviero; Lyssia Gruaz; Paolo Sfriso; Assunta Pozzuoli; Federica Frezzato; Carlo Agostini; Danielle Burger; Leonardo Punzi
Journal:  Arthritis Res Ther       Date:  2010-02-11       Impact factor: 5.156

8.  Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

Authors:  Sanjay Kumar; Charles R Hanning; Michael R Brigham-Burke; David J Rieman; Ruth Lehr; Sanjay Khandekar; Robert B Kirkpatrick; Gilbert F Scott; John C Lee; Frank J Lynch; Wentao Gao; Andrea Gambotto; Michael T Lotze
Journal:  Cytokine       Date:  2002-04-21       Impact factor: 3.861

9.  Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.

Authors:  Zhimin Miao; Changgui Li; Ying Chen; Shihua Zhao; Yangang Wang; Zhongchao Wang; Xinyan Chen; Feng Xu; Fang Wang; Ruixia Sun; Jianxia Hu; Wei Song; Shengli Yan; Cong-Yi Wang
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

10.  Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.

Authors:  L Annemans; E Spaepen; M Gaskin; M Bonnemaire; V Malier; T Gilbert; G Nuki
Journal:  Ann Rheum Dis       Date:  2007-11-02       Impact factor: 19.103

View more
  15 in total

1.  Study on the expressions of NLRP3 gene transcript variants in peripheral blood monocytes of primary gout patients.

Authors:  Wantai Dang; Dan Xu; Wenguang Xie; Jingguo Zhou
Journal:  Clin Rheumatol       Date:  2018-06-26       Impact factor: 2.980

Review 2.  Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.

Authors:  Nicola Dalbeth; Hyon K Choi; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

Review 3.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

Review 4.  Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases.

Authors:  Xinrui Li; Bing Yan; Jin Du; Shanshan Xu; Lu Liu; Caifei Pan; Xianhui Kang; Shengmei Zhu
Journal:  Brain Sci       Date:  2022-05-31

Review 5.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

6.  Tuberculosis-sensitized monocytes sustain immune response of interleukin-37.

Authors:  Jun-Ai Zhang; Gan-Bin Liu; Bi-Ying Zheng; Yuan-Bin Lu; Yu-Chi Gao; Xiao-Zhen Cai; You-Chao Dai; Shi-Yan Yu; Yan Jia; Chen Chen; Ze-Gang Zhuang; Xin Wang; Wan-Dang Wang; Xiao-Xia Fu; Lai-Long Yi; Ling Shen; Zheng W Chen; Jun-Fa Xu
Journal:  Mol Immunol       Date:  2016-09-29       Impact factor: 4.407

Review 7.  What makes gouty inflammation so variable?

Authors:  Robert Terkeltaub
Journal:  BMC Med       Date:  2017-08-18       Impact factor: 8.775

8.  IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner.

Authors:  Mingsheng Zhao; Yulan Li; Chun Guo; Liyang Wang; Hongxia Chu; Faliang Zhu; Yan Li; Xiaoyan Wang; Qun Wang; Wei Zhao; Yongyu Shi; WanJun Chen; Lining Zhang
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

9.  Anti‑gouty arthritis and anti‑hyperuricemia properties of celery seed extracts in rodent models.

Authors:  Shaopeng Li; Lanzhou Li; Han Yan; Xue Jiang; Weiwei Hu; Ning Han; Di Wang
Journal:  Mol Med Rep       Date:  2019-09-26       Impact factor: 2.952

Review 10.  Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells.

Authors:  Xianfeng Yan; Bin Xie; Guihai Wu; Jing Hu; Di Wang; Xiangna Cai; Jilin Li
Journal:  Mediators Inflamm       Date:  2019-01-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.